Unveiling Key Insights on Solventum Stock

Solventum logged a -3.1% change during today's morning session, and is now trading at a price of $63.11 per share. The S&P 500 index moved 1.0%. SOLV's trading volume is 944,619 compared to the stock's average volume of 2,882,337.

Solventum trades -9.42% away from its average analyst target price of $69.67 per share. The 3 analysts following the stock have set target prices ranging from $69.0 to $70.0, and on average have given Solventum a rating of hold.

If you are considering an investment in SOLV, you'll want to know the following:

  • Solventum has moved -5.8% over the last year, and the S&P 500 logged a change of 26.2%

  • SOLV has a forward P/E ratio of 10.8 based on its forward 12 month price to earnings (EPS) of $5.84 per share

  • Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.

  • Based in Saint Paul, the company has 22,000 full time employees and a market cap of $10.9 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.